Litcius/Paper detail

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella, Gaetano Santulli

2020Journal of Clinical Medicine570 citationsDOIOpen Access PDF

Abstract

The symptoms most commonly reported by patients affected by coronavirus disease (COVID-19) include cough, fever, and shortness of breath. However, other major events usually observed in COVID-19 patients (e.g., high blood pressure, arterial and venous thromboembolism, kidney disease, neurologic disorders, and diabetes mellitus) indicate that the virus is targeting the endothelium, one of the largest organs in the human body. Herein, we report a systematic and comprehensive evaluation of both clinical and preclinical evidence supporting the hypothesis that the endothelium is a key target organ in COVID-19, providing a mechanistic rationale behind its systemic manifestations.

Topics & Concepts

MedicineDiabetes mellitusCoronavirus disease 2019 (COVID-19)ThrombosisIntensive care medicineDiseaseEndotheliumKidney diseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Venous thrombosisBlood pressure2019-20 coronavirus outbreakKidneyInternal medicinePathologyInfectious disease (medical specialty)EndocrinologyOutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Cardiovascular Disease and Adiposity
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence | Litcius